Eye-tracking Training for Older Adults
Eye Tracking as an Early Cognitive Intervention for Older Adults With Subjective Memory Complaints
The goal of this clinical trial is to learn if a computerized eye-tracking training program can improve mental health and thinking skills in older adults. The main questions it aims to answer are whether eye-tracking training can lower depressive and anxiety symptoms in older adults, and whether it can improve their ability to control impulses and pay attention.
Researchers will compare older adults who receive eye-tracking training to older adults on a waitlist to see if eye-tracking training leads to greater improvements in mood and thinking skills.
Researchers will randomly assign participants into the experimental group or the waitlist control group. Participants in the experimental group will take part in eye-tracking training three times a week for 18 sessions, over about 1.5 months. Before and after training, participants will answer questions about their mood and take tests of memory, attention, and impulse control. Older adults on the waitlist will complete the same tests but will not receive training until after the study period; they will be offered the same training once their waiting period ends.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Hong Kong, Hong Kong, 0000
- Research Center for Neuropsychological Well-being
-
Hong Kong, Hong Kong
- International Women's League Neighbourhood Elderly Centre
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Community-dwelling Chinese older adults aged 60 to 80 years
- Able to understand Cantonese/Chinese
- Normal or corrected-to-normal vision
- Willing and able to commit to attending 18 training sessions over the course of the intervention
Exclusion Criteria:
- A history of learning disability, psychiatric disorders, neurological disorders (e.g., head injury or Parkinson's disease), visual and/or hearing impairments, or any other physical disabilities that would affect their performance on neuropsychological assessment or adherence to the intervention
- Prior or concurrent participation in other interventions involving eye-tracking techniques
- Signs of dementia, as indicated by a total score of 18 or below on the Hong Kong version of Montreal Cognitive Assessment (HK-MoCA)
- Inability to commit to the full course of 18 training sessions
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Eye-Tracking Training
Participants receive computerized eye-tracking training for 18 one-hour sessions, three times weekly, over approximately 6 weeks.
|
The intervention is a copyrighted computerized training program using a non-contact eye tracker.
Participants are required to fixate on or trace visual targets across six modules of increasing difficulty to improve attention and inhibitory control.
|
|
Sem intervenção: Waitlist control
Participants in this group do not receive eye-tracking training during the study period and complete the same baseline and post-assessment schedule as the experimental group.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Inhibitory control
Prazo: Baseline and after completion of 18 training sessions (approximately 9 weeks)
|
Inhibitory Control Index (ICI) in the Eriksen Flanker Test
|
Baseline and after completion of 18 training sessions (approximately 9 weeks)
|
|
Sustained attention
Prazo: Baseline and after completion of 18 training sessions (approximately 9 weeks)
|
Digit Cancellation Index (DCI) in the Digit Cancellation Test
|
Baseline and after completion of 18 training sessions (approximately 9 weeks)
|
|
Depressive symptoms
Prazo: Baseline and after completion of 18 training sessions (approximately 9 weeks)
|
Depressive symptoms are assessed using the 15-item Chinese version of Geriatric Depressive Scale (CGDS-15).
It is a 15-item self-report scale in which participants answer "Yes" or "No" to whether they experienced each of 15 common depressive symptoms in the past week.
Scores range from 0 to 15, with higher scores indicating more depressive symptoms.
A score of 8 or higher indicates clinically significant depressive symptoms.
|
Baseline and after completion of 18 training sessions (approximately 9 weeks)
|
|
Anxiety symptoms
Prazo: Baseline and after completion of 18 training sessions (approximately 9 weeks)
|
Anxiety symptoms are assessed using the 10-item Chinese version of Geriatric Anxiety Scale (CGAS-10).
It is a 10-item self-report measure of anxiety symptoms in older adults.
Higher scores indicate greater severity of anxiety symptoms.
|
Baseline and after completion of 18 training sessions (approximately 9 weeks)
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2022.625
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .